Numerous studies have shown that MMP-2 is overexpressed in various human tumours, including breast cancer [22–27], lung cancer [28], colorectal tumours [29], pancreatic carcinoma [30], and gastric and esophageal cancers [31–35]. Here, MMP2 is linked to neoplasm.